Quick Facts

Lisinopril GenRx is indicated for the management of:

• High blood pressure (hypertension).
• Heart failure (as part of a comprehensive treatment regimen).
• Management following a heart attack (acute myocardial infarction).

---

Lisinopril GenRx is used in the treatment of specific cardiovascular conditions. It is primarily indicated for the management of high blood pressure, also known as hypertension, where it assists in sustaining healthy blood pressure levels. This therapeutic action may contribute to a reduction in the overall workload on the heart and blood vessels.

The medication is also utilized as a supportive measure in the management of heart failure, forming a component of the comprehensive treatment strategy for this chronic condition. Additionally, in patients who have experienced an acute myocardial infarction (a heart attack), Lisinopril is used as part of the stabilization and post-event management plan. Your doctor or qualified health professional determines the appropriate role of Lisinopril in your individualized care plan.

Regulatory References

1. NIH MedlinePlus guidance

This section outlines the official population eligibility and non-eligibility for Lisinopril GenRx, as defined by government regulatory documents.

Contraindicated Populations

Lisinopril is contraindicated (must not be used) in the following groups:

• Patients with a history of angioedema related to a previous ACE inhibitor or those with hereditary/idiopathic angioedema.
• Pregnant women, particularly during the second and third trimesters, due to the risk of fetal injury and death.
• Diabetic patients concurrently taking any medication containing aliskiren.
• Patients who are concurrently taking or who have taken a neprilysin inhibitor (e.g., sacubitril) within the last 36 hours.

Age and Condition-Based Eligibility

Population Category	Eligibility Status (Official Label)
Children under 6 years old	Safety and effectiveness are not established for hypertension treatment.
Children 6–16 years old	Approved for hypertension, provided the Glomerular Filtration Rate (GFR) is 30 mL/min/1.73 m^2.
Renal Impairment	Requires initial dose adjustment in adults with CrCl leq 30 mL/min.
Pregnancy/Lactation	Contraindicated in later pregnancy. Use is not recommended while breastfeeding.

Use requires special consideration and caution in patients with hepatic impairment, severe aortic stenosis, or those who are volume-depleted.

Interactions with other medicines and products

Lisinopril GenRx, an ACE Inhibitor, has officially documented interaction patterns primarily concerning its effects on blood pressure, the RAAS, and electrolyte balance, as detailed in regulatory documents.

Contraindicated Combinations

The co-administration of Lisinopril with Neprilysin Inhibitors (e.g., Sacubitril/Valsartan) is strictly prohibited due to the heightened risk of angioedema. A mandatory minimum 36-hour separation window is required when switching between these agents. Lisinopril is also contraindicated with the direct renin inhibitor Aliskiren in patients with diabetes or moderate-to-severe renal impairment (GFR less than 60 mL/min/1.73 m²).

Pharmacodynamic and Exposure Interactions

Agents Affecting Potassium: Co-administration with potassium-sparing diuretics (e.g., spironolactone) or potassium supplements is generally not recommended due to the significant risk of hyperkalemia (elevated potassium levels).

Blood Pressure and Renal Effects: The concomitant use of NSAIDs (Non-Steroidal Anti-Inflammatory Drugs) may diminish Lisinopril’s blood pressure-lowering effect and can increase the risk of worsening renal function. The combined use of Lisinopril with other blood pressure agents, such as Angiotensin II Receptor Blockers (ARBs), is not recommended due to increased risks of hyperkalemia and hypotension.

Other Agents: Lisinopril may cause reversible increases in serum concentrations of Lithium, potentially leading to toxicity. The combination of Lisinopril with mTOR inhibitors (e.g., sirolimus) increases the risk of angioedema.

Lisinopril is a competitive inhibitor of the Angiotensin-Converting Enzyme (ACE), a key enzyme within the Renin-Angiotensin-Aldosterone System (RAAS). ACE is responsible for catalyzing the conversion of the inactive decapeptide Angiotensin I into the octapeptide Angiotensin II

. By binding competitively to the ACE active site, Lisinopril reduces the enzyme's capacity to synthesize Angiotensin II.

This immediate pathway modulation leads to a dose-dependent reduction in circulating Angiotensin II levels. Angiotensin II is a primary stimulus for the release of the hormone aldosterone from the adrenal cortex. Consequently, the reduction of Angiotensin II concentration results in decreased aldosterone secretion and an increase in bradykinin levels. The net physiological consequence of this multi-step cascade is reduced vasoconstriction in the vascular smooth muscle and a corresponding decrease in peripheral vascular resistance.

Official Administration Guidelines for Lisinopril

Lisinopril is an oral medication taken once daily at approximately the same time each day. It is available as oral tablets in strengths ranging from 2.5 mg to 40 mg, and as a 1 mg/mL oral solution.

Administration and Dosing Schedule

Route of Administration: Oral (by mouth).

Timing: Lisinopril absorption is not influenced by food, allowing for administration with or without meals.

Standard Dosing Ranges for Adults:	Indication	Initial Adult Dose	Typical Maintenance Dose
Hypertension	10 mg once daily (or 5 mg if on diuretic)	20 mg to 40 mg once daily
Heart Failure	2.5 mg to 5 mg once daily	5 mg to 40 mg once daily

The daily dose is typically titrated (gradually increased) by a healthcare provider over intervals of no less than 2 to 4 weeks, based on patient response.

Special Administration Conditions

Renal Impairment: Dosing must be adjusted for patients with reduced kidney function (Creatinine Clearance < 30 mL/min). The recommended initial dose may be halved (e.g., to 2.5 mg) and the dose titrated cautiously.

Pediatric Use: For hypertensive children ge 6 years old, the initial dose is weight-based (0.07 mg/kg once daily), up to a maximum initial dose of 5 mg.

Missed Dose: If a dose is missed, take it as soon as possible. If it is almost time for the next scheduled dose, skip the missed dose and resume the regular schedule. A double dose should not be taken to make up for a missed one.

Research evidence / Overview of Studies for Lisinopril GenRx

Evidence for Use in High Blood Pressure (Hypertension)

The research exploring Lisinopril GenRx for high blood pressure was primarily conducted using large-scale Randomized Controlled Trials (RCTs). These studies involved comparison against a placebo or against other established treatments. Researchers focused on objectively monitoring blood pressure measurements, specifically the changes in systolic and diastolic pressure, and tracking whether participants reached predetermined pressure goals.

Long-term research also examined outcomes such as heart attack (myocardial infarction) or stroke. The data described measurements of lower systolic and diastolic blood pressure compared to baseline in the observed populations. Research highlights changes measured during the study period, with large-scale systematic reviews describing patterns observed related to cardiovascular event measurements.

Evidence for Use in Heart Failure

The evidence framework is based on large, multicenter Randomized Controlled Trials that explored the use of Lisinopril GenRx in heart failure. These studies explored its use as part of a comprehensive treatment regimen in adult patients with chronic systolic heart failure.

The main outcomes related to systemic or functional imbalance that were monitored included all-cause mortality and hospitalization rates for heart failure. Across the major trials, the treated groups were observed to have lower measurements of all-cause mortality and hospitalization measurements for heart failure compared to control groups over the duration of the studies.

What Research Gaps and Uncertainty Remain

While the core indications are supported by high-quality RCTs, some limitations persist in the evidence landscape. For example, evidence is limited regarding the use or observations of Lisinopril GenRx in patients who are hemodynamically unstable during an acute heart attack, as trials specifically excluded these individuals.

In some demographic groups, such as those with certain racial/ethnic backgrounds, evidence suggests that the use of Lisinopril as a single medicine may not be associated with the same magnitude of pressure reduction compared to others. Findings describe group patterns, not personal outcomes, and research provides context but not individual predictions. The study results reflect the specific conditions under which they were conducted.

Key Studies & References

1. Hypertension in adults: diagnosis and management (NICE Guideline NG136)

Common questions about Lisinopril GenRx (FAQ)

Q: What is Lisinopril GenRx used for?

Lisinopril GenRx is an ACE inhibitor used primarily to treat high blood pressure (hypertension). It is also used to treat heart failure and to help improve survival after a heart attack in certain patients.

---

Q: How does Lisinopril GenRx work?

Lisinopril GenRx works by blocking a substance in the body that causes blood vessels to narrow. By blocking this substance, lisinopril causes the blood vessels to relax and widen, which lowers blood pressure. This reduction in blood pressure helps more blood and oxygen reach the heart and reduces the workload on the heart.

---

Q: What are the common side effects of Lisinopril GenRx?

Common side effects of Lisinopril GenRx can include:

• Dry, persistent cough
• Dizziness or lightheadedness (especially when standing up quickly)
• Headache
• Fatigue

These side effects are often mild and may lessen as your body adjusts to the medication. It is important to discuss any persistent side effects with a healthcare provider.

---

Q: Can I stop taking Lisinopril GenRx if my blood pressure improves?

No, you should not stop taking Lisinopril GenRx without first consulting your healthcare provider. Even if your blood pressure readings are within a healthy range, high blood pressure is often a chronic condition that requires continuous treatment. Stopping the medication abruptly can cause your blood pressure to rise suddenly, which may increase the risk of a heart attack or stroke.

Storage and Disposal Requirements for Lisinopril GenRx

Lisinopril tablets must be stored at Controlled Room Temperature (CRT), defined as 20 C to 25 C (68 F to 77 F).

Required Conditions

Condition	Requirement
Temperature	Store at 20 C to 25 C; protect from excessive heat.
Protection	Protect from moisture and do not freeze.
Container	Dispense and store in a tight container and the original package.
Safety	Keep out of the reach of children.

Disposal Instructions

Discard any unused or expired Lisinopril tablets in accordance with local requirements for pharmaceutical waste. Official labeling mandates following established local protocols for safe disposal.